Pieber TR, Bode B, Mertens A, Cho YM, Christiansen E, Hertz CL, Wallenstein SO, Buse JB, Akn S, Alada N
This uncertainty forms a central litigation allegation manufacturers rushed medications to market and promoted them for off-label weight loss without adequately studying or disclosing potential permanent digestive damage
NAD+ helps bridge this gap by promoting mitochondrial efficiency, improving metabolic flexibility, and supporting the cellular repair processes that are taxed during rapid weight loss
Molecular Therapy Oncology, 33 (1)
and our high-concentration Tri-immune boost